Roxagen Tablet 20 mg contains Roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) used to treat anemia associated with chronic kidney disease (CKD). Roxadustat stimulates the body’s natural production of erythropoietin, promoting red blood cell production and improving hemoglobin levels. It offers an effective alternative to injectable erythropoiesis-stimulating agents (ESAs), helping CKD patients manage anemia, reduce fatigue, and enhance quality of life.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Roxadustat 20 mg
• Dosage Form: Oral tablet

Indications

Roxagen Tablet 20 mg is indicated for:

• Treatment of anemia in patients with chronic kidney disease (CKD), including non-dialysis and dialysis-dependent patients
• Management of low hemoglobin levels associated with CKD
• Reducing the need for red blood cell transfusions in CKD patients

Mechanism of Action

Roxadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It stabilizes hypoxia-inducible factors (HIFs), which regulate the body’s response to low oxygen levels. This leads to:

• Increased endogenous erythropoietin production in the kidneys and liver
• Enhanced iron absorption and mobilization from body stores
• Improved red blood cell production and hemoglobin synthesis

By targeting the natural pathways of erythropoiesis, Roxagen effectively treats anemia while minimizing the need for frequent injections.

Dosage and Administration

• Typically administered orally 2–3 times per week or as directed by a physician
• Swallow the tablet whole with water; can be taken with or without food
• Dosage should be individualized based on hemoglobin response and patient condition
• Regular monitoring of hemoglobin, iron levels, and kidney function is recommended

Benefits

• Oral treatment option for CKD-associated anemia
• Stimulates natural erythropoietin production
• Reduces fatigue and improves quality of life
• Decreases the need for red blood cell transfusions
• Supports effective anemia management in both dialysis and non-dialysis CKD patients

Possible Side Effects

Common side effects:

• Headache
• Nausea or vomiting
• Diarrhea
• Elevated blood pressure

Serious side effects (rare):

• Blood clot formation (thrombosis)
• Cardiovascular complications
• Severe allergic reactions

Patients should seek medical attention if they experience unusual swelling, chest pain, shortness of breath, or severe headaches.

Precautions and Warnings

• Use with caution in patients with a history of cardiovascular disease, hypertension, or thromboembolic events
• Regular blood tests are required to monitor hemoglobin and iron levels
• Not recommended for patients with uncontrolled hypertension or known hypersensitivity to Roxadustat
• Inform your healthcare provider of all concurrent medications to avoid interactions

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store at room temperature (15°C–30°C)
• Protect from moisture and direct sunlight
• Keep out of reach of children

Conclusion

Roxagen Tablet 20 mg (Roxadustat) is an effective oral therapy for anemia in chronic kidney disease. By stimulating natural erythropoietin production and improving iron utilization, it helps CKD patients increase hemoglobin levels, reduce fatigue, and improve overall quality of life while minimizing the need for injectable treatments.